Lucid Diagnostics Inc. (LUCD) financial statements and ratios from SEC XBRL: revenue $4.71M (TTM), net margin -1232.7%, revenue growth 26.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.71M |
| Net Margin | -1232.7% |
| Revenue Growth (YoY) | 26.7% |
| EPS Growth (YoY) | 0.0% |
| FCF Growth (YoY) | 7.0% |
| Price / Book | 17.86 |
| Price / Sales | 35.84 |
| FCF Yield | -12.1% |
| Altman Z-Score | -9.71 (distress) |
| Sector P/E (Healthcare) | 21.6 |
LUCD overview · LUCD earnings · LUCD KPIs · LUCD investor relations · LUCD ownership · LUCD peers · LUCD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.